The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats - PubMed (original) (raw)
The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats
E Lorenc-Koci et al. Neuroscience. 2008.
Abstract
The contribution of (R)-enantiomer of N-methyl-salsolinol (1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; NMSal) to the degeneration of dopaminergic neurons in the course of Parkinson's disease (PD) has been predominantly suggested by in vitro experiments in cell culture and by an in vivo study in which this compound has been directly injected into the rat striatum. The aim of the present study was to examine the effects of racemic NMSal (50 and 100 mg/kg) administered systemically, acutely and chronically for 21 days to rats, on the neurochemical and behavioral markers of PD. Our results showed that racemic NMSal easily penetrated the blood-brain barrier. Its brain level was relatively high 2-6 h after a single injection than gradually decreased. NMSal was quickly eliminated from the rat brain, its concentration 24 h after withdrawal from chronic treatment was very low. NMSal at both examined doses did not affect striatal and nigral levels of dopamine (DA) 2 h after the first and last chronic injections, however, it markedly changed DA catabolism. In the striatum both its doses evoked a significant acceleration of the total and oxidative, monoamine oxidase (MAO)-dependent DA catabolism without affecting the catechol-O-methyltransferase (COMT)-dependent O-methylation. In the substantia nigra (SN), only the higher dose of NMSal produced such effect. DA catabolism in either structure was the same as in control 24 h after cessation of chronic treatment. The second characteristic marker of PD, the number of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the SN, was not affected by chronic NMSal treatment as revealed by the stereological counting. In the behavioral study, it was found that racemic NMSal significantly suppressed spontaneous locomotor activity and effectively prevented that stimulated by apomorphine. Our results suggest that NMSal may play an important role in the regulation of dopaminergic activity rather than in inducing changes of parkinsonian type.
Similar articles
- The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.
Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P. Iravani MM, et al. Eur J Neurosci. 2005 Jul;22(2):317-30. doi: 10.1111/j.1460-9568.2005.04220.x. Eur J Neurosci. 2005. PMID: 16045485 - Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response.
Iravani MM, Sadeghian M, Leung CC, Tel BC, Rose S, Schapira AH, Jenner P. Iravani MM, et al. Exp Neurol. 2008 Aug;212(2):522-31. doi: 10.1016/j.expneurol.2008.04.037. Epub 2008 May 14. Exp Neurol. 2008. PMID: 18571649 - Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F. Ahmad M, et al. J Neurochem. 2005 Apr;93(1):94-104. doi: 10.1111/j.1471-4159.2005.03000.x. J Neurochem. 2005. PMID: 15773909 - R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
Knoll J. Knoll J. J Neural Transm Suppl. 1987;25:45-66. J Neural Transm Suppl. 1987. PMID: 2828537 Review. - Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Naoi M, Maruyama W, Nagy GM. Naoi M, et al. Neurotoxicology. 2004 Jan;25(1-2):193-204. doi: 10.1016/S0161-813X(03)00099-8. Neurotoxicology. 2004. PMID: 14697894 Review.
Cited by
- Chronic salsolinol administration prevents the behavioral and neurochemical effects of L-DOPA in rats.
Wąsik A, Romańska I, Michaluk J, Antkiewicz-Michaluk L. Wąsik A, et al. Neurotox Res. 2015 May;27(4):399-410. doi: 10.1007/s12640-015-9523-2. Epub 2015 Feb 25. Neurotox Res. 2015. PMID: 25711629 Free PMC article. - Chiral capillary electrophoresis-mass spectrometry of tetrahydroisoquinoline-derived neurotoxins: observation of complex stereoisomerism.
Wu H, Yuan B, Liu YM. Wu H, et al. J Chromatogr A. 2011 May 20;1218(20):3118-23. doi: 10.1016/j.chroma.2011.03.026. Epub 2011 Mar 21. J Chromatogr A. 2011. PMID: 21470616 Free PMC article. - Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells.
Hellmann-Regen J, Gertz K, Uhlemann R, Colla M, Endres M, Kronenberg G. Hellmann-Regen J, et al. Eur Arch Psychiatry Clin Neurosci. 2012 Dec;262(8):697-704. doi: 10.1007/s00406-012-0309-8. Epub 2012 Mar 21. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22434147 - Salsolinol: an Unintelligible and Double-Faced Molecule-Lessons Learned from In Vivo and In Vitro Experiments.
Kurnik-Łucka M, Panula P, Bugajski A, Gil K. Kurnik-Łucka M, et al. Neurotox Res. 2018 Feb;33(2):485-514. doi: 10.1007/s12640-017-9818-6. Epub 2017 Oct 23. Neurotox Res. 2018. PMID: 29063289 Free PMC article. Review. - Crystal structure of 2-methyl-1,2,3,4-tetra-hydro-iso-quinoline trihydrate.
Langenohl F, Otte F, Strohmann C. Langenohl F, et al. Acta Crystallogr E Crystallogr Commun. 2020 Feb 6;76(Pt 3):298-302. doi: 10.1107/S2056989020000730. eCollection 2020 Mar 1. Acta Crystallogr E Crystallogr Commun. 2020. PMID: 32148864 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous